Why Medpace Holdings, Inc. (MEDP) Stock Rose 14.7% on Jul 23, 2026
What happened
Medpace Holdings filed an 8-K material event form today alongside its earnings report, driving a sharp 13.96% rally to $601.85. Volume surged to 5.65x the expected level for this time of session, signaling strong institutional interest in the disclosed event.
Medpace expects Q3 2026 earnings on October 28, with backlog conversion and oncology pipeline growth as near-term catalysts.
Other developments that session
Medpace Holdings, Inc. (MEDP) moved -6.36% from $647.00 to $605.82 on 2026-07-23, the day after reporting Q2 FY2026 earnings that beat consensus: EPS of $4.25 vs. estimate $3.98 (+6.78% surprise). Volume was 3.7x the 5-day average.
Medpace Holdings, Inc. (MEDP) filed a new 10-Q on July 23, 2026.
Frequently asked questions
Why did Medpace Holdings, Inc. (MEDP) stock rise on Jul 23, 2026?
Medpace Holdings filed an 8-K material event form today alongside its earnings report, driving a sharp 13.96% rally to $601.85. Volume surged to 5.65x the expected level for this time of session, signaling strong institutional interest in the disclosed event.
How much did MEDP stock rise on Jul 23, 2026?
MEDP rose 14.7% during the Jul 23, 2026 trading session.